Associated Papers
Treatment with checkpoint inhibitors in a metastatic colorectal cancer patient with molecular and immunohistochemical heterogeneity in MSI/dMMR status.
Loupakis F et al.
Journal for Immunotherapy of Cancer, 2019
31703605 (PubMed )
Supplement: 40425_2019_788_MOESM3_ESM.pdf
Select a paper to view details